Activist short-seller Spruce Point Capital Management is taking aim at medical device company Stryker (SYK).
Spruce Point unveiled its latest attack on Wednesday, saying Stryker has overpaid for recent acquisitions, has used questionable accounting practices and has executive compensation that isn’t aligned with shareholder interests. The activist has called on Harvard Business School dean and Stryker audit committee member Srikant Datar to evaluate its findings with “independent forensic…
Source link
